ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd. (ProSpec). In the beginning of 2013, LifeMap Sciences will be offering more than a 1000 recombinant proteins and antibodies, many of which are related to stem cell research, such as growth factors, signaling molecules, differentiation factors, hormones, cytokines and chemokines. LifeMap Sciences is the principal marketing and sales arm for BioTime’s cell-based products and related reagents for research use in academia, research hospitals, and biotech and pharma companies. ProSpec’s innovative products will complement the current BioTime research product lines available via the recently launched LifeMap BioReagents™ portal, including PureStem™ human progenitor cell lines, PureStem™ packages, clinical and research grade human embryonic stem cell lines (hES), HyStem® hydrogels, culture media, and cell differentiation kits.
